K. Langley

ANTIBODY AND ANTIGEN ON TTP OUTCOMES 1 Title : Presenting ADAMTS 13 antibody and antigen levels predict prognosis in immune-mediated Thrombotic Thrombocytopenic Purpura Running Title : ADAMTS 13 antibody and antigen on TTP outcomes

R. Gooding, T. Biss, M. Scully, 2017 .

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.

R. Gooding, T. Biss, M. Scully, 2017, Blood.

A comparative evaluation of the CN‐6000 haemostasis analyser using coagulation, amidolytic, immuno‐turbidometric and light transmission aggregometry assays

I. Mackie, S. Machin, C. Gardiner, 2020, International journal of laboratory hematology.

Multiple centre evaluation study of ADAMTS13 activity and inhibitor assays

S. Kitchen, M. Scully, S. MacDonald, 2018, International journal of laboratory hematology.

Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes.

H. Watson, F. Ní Áinle, M. Scully, 2014, Blood.

Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies

F. Peyvandi, R. Liesner, M. Scully, 2013, Thrombosis and Haemostasis.

Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies

F. Peyvandi, R. Liesner, M. Scully, 2013, Thrombosis and Haemostasis.